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Abstract We have established a novel method of molecular cloning of endothelin converting enzyme, a key enzyme in the production of a potent 
vasoconstrictor endothelin-1, by modification of the reverse hemolytic plaque assay. Also, we demonstrated that a cell line, CHO-K1, showed no 
detectable activity of endothelin converting enzyme. This cell line was transfected with a cDNA library of bovine ndothelial cells. The modified reverse 
hemolytic plaque assay was shown to detect even a single CHO-K1 cell that was changed to produce mature ET-1 by transfection. Thus, this novel 
method is suggested to be useful for the molecular cloning of other secreted antigens and their processing enzyme. 
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1. Introduction 2. Materials and methods 
Endothelin-I (ET-1) is a potent vasoconstrictive 21-amino- 
acid peptide produced by vascular endothelial cells. Endothelin 
converting enzyme (ECE) is a key enzyme in the synthesis of 
ET-1. It converts an intermediate form of endothelin-1, big 
endothelin- 1 (big ET-1), to the mature form [1], by cleaving the 
Trp21-Va122 bond of big ET-1. This substrate specificity of ECE 
seems to be unique for this enzyme. The conversion is essential 
in the pressor esponse to big ET-1, because the vasocontractile 
activity of ET-1 is higher than that of big ET-1 by two orders 
of  magnitude [3], and phosphoramidon, an inhibitor of ECE 
[4-7], blocked the vasocontractile activity of big ET-1. This 
result also suggests an involvement of ECE in the regulation of  
vascular tonus. Involvement of ET-1 in the pressor esponse is 
suggested by the fact that an antagonist of  the ET receptor 
effectively decreases the mean arterial pressure of sodium-de- 
pleted squirrel monkeys [8]. Accordingly, an expectation that 
the inhibitors of ECE block the production of ET-1 and subse- 
quently depress the ET-dependent regulation of  vascular tonus 
has prompted us to investigate the properties of ECE. The 
deternaination of the structure of  ECE is an inevitable step for 
the elucidation of the role of ECE. 
To elucidate this mechanism, isolation of  the cDNA clone for 
ECE is an essential step, We devised a novel method of detec- 
tion of  a single cell that produces mature ET-1. We found also 
that CHO-K I  cells can produce big ET-1, but not mature ET-1, 
because of the lack of  phosphoramidon-sensitive ECE activity. 
Then, the CHO-K I  cells were transfected with the cDNA li- 
brary of  endothelial cells. We successfully detected a trans- 
fected single CHO-K1 cell that produced mature ET-I by this 
new method. 
*Corresponding author. Fax: (81) (75) 753 4402. 
Abbreviations." ET-1, endothelin-1; big ET-1, big endothelin-l; ECE, 
endothelin converting enzyme. 
2.1. Cell culture 
Bovine aortic endothelial cells (BAE) were harvested by gently scrap- 
ing the inner wall of fresh thoracic aortas with a cover glass. The 
isolated BAE were maintained in Dulbecco's modified Eagle's medium 
(DMEM; Nissui) supplemented with 10% fetal calf serum (FCS) at 
37°C in a humidified atmosphere containing 5% CO2. The CHO-K1 
cells were maintained in Ham's F12 medium (Nissui), supplemented 
with 10% fetal calf serum (FCS) at 37°C under the same conditions as 
described above. 
2.2. Enzyme immunoassay 
ET-1 and big ET-1 were measured by the sandwich enzyme immu- 
noassay as described previously [9,10]. 
2.3. Measurement of ECE activity 
A confluent culture of BAE or CHO-KI in 10-cm dishes was washed 
twice with phosphate-buffered saline. Cells were harvested with a rub- 
ber scraper in 5 ml of t0 mM Tris-HC1 (pH 7.7). Then, the cells were 
homogenized by a polytron homogenizer at the maximum speed. The 
membrane fraction was prepared and solubilized in 100 pl of 10 mM 
Tris-HC1 (pH 7.7), 0.1% (w/v) Lubrol PX as described previously [11]. 
One ,ul of solubilized membrane preparation was incubated with 50 
pmol of big ET- 1 in 100/zl of buffer solution containing 0.1 M Tris-HCl 
(pH 7.0) with or without 0.1 mM phosphoramidon for 1 h at 37°C. 
Enzyme reactions were stopped by the addition of 100 pl of 0.1 M 
EDTA. Mature ET-l generated was measured by enzyme immunoas- 
say [9], 
Z 4. DEAE dextran transfection 
Subconfluent monolayers of CHO-KI grown in 6-well culture dishes 
were transfected with plasmid by a DEAE-dextran-transfection method 
with chloroquine treatment [12]. Two days after the transfection, the 
culture media were collected for measurement of concentration fET-1 
and big ET-I, and the cells were dispersed by treatment with 0.25% 
trypsin, and used for hemolytic assay as described below. 
2.5. Preparation fred blood cells coupled with protein A 
Human red blood cells (RBCs) were coupled with staphylococcal 
protein A (Pearce) using CrCI~ as described previously [13,14]. Briefly, 
0.5 mg of protein A and 1 mg of CrCI3"6HzO were mixed in 11 ml of 
saline. Then, the mixture was added with 1 ml packed volume of RBCs 
prewashed with saline. The RBSs were incubated at 30°C for 1 h, and 
then washed once with 5 ml of saline and twice with 5 ml of Ham's 
F12/0.3% BSA. The RBCs were suspended in l0 ml of Ham's F12 
containing 0.3% BSA. 
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2.6. Reverse hemolytic plaque assay 
Before the following assay, the cells were stained, if necessary, with 
5/tg/ml of FAST Dil (Molecular Probe) according to the manufac- 
turer's instructions. The cells were mixed with the RBCs coupled with 
protein A in Ham's F12/0.3% BSA containing 1 mg/ml of ascorbic acid, 
and seeded on 10 cm dishes precoated with 15/~g/ml of poly-L-lysine 
(Mr 150,000 300,000). The cells were incubated for45 rain at 37°C, and 
then washed with 5 ml of Ham's F12/0.3% BSA. Then, the culture 
media were changed to the media with anti ET-1 monoclonal antibody 
(final concentration f 5/tg/ml), guinea pig serum (final 1 : 100 dilution, 
Gibco) as a source of complement and ascorbic acid (1 mg/ml). The cells 
were further incubated at 37°C for 8 h, and observed under a micro- 
scope. We recognized a positive cell that was located in a hemolytic 
plaque. 
2.7. Introduction of a stop eodon ./or the production of mature ET-1 
(ET-stop) 
The EeoRl fragment of human ppET-1 cDNA was subcloned into 
a mammalian expression vector pMEl8sf- after digestion with BstXl 
and blunting. Using the primer (5'-GGA CAT CAT TTG GTG AAA 
CAC TCC CGA G-Y), mutagenesis was carried out by Kunkel's 
method [15] to substitute codon GTC coding Va122 of big ET-I with 
TGA coding with stop codon. Sequence of the mutant was confirmed 
by sequencing. 
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Fig. I. ECE activities in BAE and CHO-K1 cells. (A) Secretion of ET-I 
or big ET-1 from BAE and CHO-K1. Both cells were grown until they 
become confluent and cultured for 2 days. Ir-ET-I and ir-big ET-1 in 
conditioned medium of BAE and CHO/big were measured by a sand- 
wich enzyme immunoassay (see text). (B) Effect of phosphoramidon on 
ECE activity in BAE and CHO-K1 cell. One/11 of membrane fraction 
from each cell, which was dissolved in 10 mM Tris-HCl (pH 7.4) 
containing 0.1% (v/v) Lubrol PX, was incubated with 50 pmol human 
big ET-1 with or without 0.1 mM phosphoramidon for 1 h. The gener- 
ated mature ET-1 was measured by the sandwich enzyme immuno- 
assay. 
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Fig. 2. Schematic representation f the method for screening ofa cDNA 
library by the reverse hemolytic plaque assay (see text). 
2.8. Development of a stable transformant that expresses ppET-I 
(CHO/big) 
Thirty % confulent CHO-KI cells were transfected by the calcium- 
phosphate transfection method [16] with l gtg of the plasmid of the 
ppET-I cDNA subcloned in pME18sf- as described. Stable transfor- 
mants were selected in Ham's F12/10% FCS containing 1 mg/ml of 
G418 (Gibco). 
2.9. Screening of cDNA library 
A BAE cDNA library composed of 7 × 105 independent clones was 
prepared with the pME 18sf- vector (kind gift from Dr. K. M aruyama). 
Ten/lg of amplified cDNA library and 0.2/tg of pSV2bsr were co- 
transfected toCHO/big by the calcium-phosphate transfection method 
[16]. Stable transformants were selected in Ham's F12/10% FCS con- 
taining 2/.tg/ml of blasticidin S (Kaken Pharmaceutical Co.). Colonies 
were dispersed by 0.25% trypsin and used for the hemolytic assay as 
described above. 
3. Results and discussion 
3.1. CHO-K1 cells lack ECE activity 
We have elaborated the expression cloning strategy for direct 
isolation of a complementary DNA for ECE. For this strategy, 
a key point is to find a cell that lacks ECE activity. We tested 
several cell lines for whether they are capable of producing 
mature ET-1 or not. ppET-1 cDNA was introduced into vari- 
ous cell lines and the concentrations of ET-1 secreted in the 
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culture supernatant were determined. All the tested cell lines 
except CHO-K1 could produce mature ET-I even if the cell 
lines produced neither ET-1 nor big ET-1 before the transfec- 
tion. The CHO-K1 cells, after the transfection with ppET-I 
cDNA, did not secrete mature ET- 1 but secreted exclusively big 
ET-1 (Fig. 1A). 
Moreover, we could not detect phosphoramidon-sensitive 
ECE activity in membrane fractions of CHO-K1 homogenates, 
as detected in BAE (Fig. 1B). These two results indicate that 
CHO-K1 cells lack ECE. 
3.2. Reverse hemolytic plaque assay 
For the expression cloning method, sensitivity of the method 
for detection of the objective clone is important. Accordingly, 
we developed a sensitive detection method using the reverse 
hemolytic plaque assay. This assay is based on activation of 
complements mediated by an immune complex. In this assay, 
we used anti-ET-1 antibody that selectively recognized mature 
ET-1 but not big ET-1. Fig. 2 shows the schema of the expres- 
sion cloning method of ECE using the reverse hemolytic assay. 
CHO/big was transfected by a BAE cDNA library, and the 
stable transformants were selected. The stable transformant 
cells were cultured in the presence of RBCs conjugated with 
protein A, anti ET- 1 antibody and complement. Hemolysis wa
observed around the transformants hat produced ET-1 in the 
presence of complement activated by the antibody-antigen 
complex. 
To examine whether cells producing mature ET-1 were de- 
tected by this hemolytic assay, CHO-K1 cells were transfected 
with the ET-1 cDNA construct, in which the codon coding 
Va122 was replaced with stop codon. These cells produced ma- 
ture ET-1 (data not shown). We could successfully detect 
ET-l-producing CHO-K1 cells by the hemolytic assay (Fig. 
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Fig. 3. Detection of single ET-1-producing cells by reverse hemolytic 
plaque assay. (A) Detection of a transfected CHO-KI that produces 
mature ET-1. Plaques were formed around the CHO-K1 cells trans- 
fected with ET-stop (see text). (B) No plaque formation was observed 
around the CHO/big cells. The CHO/big cells were stained in advance 
with a fluorescent dye, Dil. (C,D) Detection of BAE in the mixed 
culture of BAE and CHO/big cells. Plaques were formed only around 
BAE (C, arrow) but not around CHO/big cells visualized with DiI (D, 
arrowhead). 
Fig. 4. Typical plaque formed around CHO/big cells after transfection 
with the BAE cDNA library. 
3A). On the other hand, the CHO/big cells did not form hemo- 
lytic plaques (Fig. 3B). Then, we examined whether we could 
discriminate ET-l-producing cells from ET-l-non-producing 
cells in the mixed culture of these cells. We performed the 
hemolytic assay with the mature ET-1-producing BAE cells and 
the non-producing CHO-K1 cells. As shown in Fig. 3C,D, 
plaques were formed around BAE but not around CHO-K1 
cells. The latter CHO-K1 cell was prestained with DiI. This 
result indicates that discrimination of BAE from CHO-K1 by 
this method was easy. 
3.3. Genetic transfer of ECE activity 
To isolate a cDNA for ECE, we used a BAE cDNA library 
composed of 7 × 105 independent clones for the transfection. 
We carried out a hemolytic assay of the stable transformants 
transfected with the BAE cDNA library. We found several 
plaques formed around a single cell (Fig. 4). This fact implies 
that ECE activity was genetically transferred to CHO/big cells. 
Despite numerous reports on the molecular cloning of the 
membrane bound antigens by the 'panning' method [12,17], no 
effective strategy for the cloning of a secreted antigen has been 
described. In the present study, we have developed an expres- 
sion cloning system for the molecular cloning of secreted anti- 
gens and the enzymes that produce the secreted antigens. This 
novel system based on a reverse hemolytic plaque assay has the 
following advantages for the molecular cloning of the secreted 
proteins. First, identification of positive cells in mixed culture 
is easy under the light microscope. Secondly, the identified cells 
can subsequently be kept growing, since this assay is carried out 
on living cells. Accordingly, the resulting colony formed can be 
easily picked up. Our method could be applied to the cloning 
of other secreted antigens and their processing enzymes. 
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